| 101348-1 |
Palmitoyl protein thioesterase & Tripeptidyl peptidase I panel |
- |
Bld.dot |
Pt |
- |
|
|
ACTIVE |
Palmitoyl protein thioesterase and Tripeptidyl peptidase I panel - DBS |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
101348-1 |
|
|
|
|
Order |
|
|
|
0 |
NCLBS DBS |
|
|
|
N |
|
Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; NCLBS; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; PPT; PR; Prot; Random; WB; Whole blood |
2.75 |
2.74 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 101349-9 |
Jurisdiction where advance directive is accepted |
Loc |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Jurisdiction where advance directive is accepted [Location] |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HL7.CCDA |
|
101349-9 |
|
|
|
|
Observation |
|
|
|
0 |
Jurisdiction where adv direct accepted |
|
|
|
N |
|
Advanced; directives; HL7CCDA; Jurisdiction where adv direct accepted; Location; Nominal; Point in time; Random |
2.74 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 10135-2 |
T' wave amplitude.lead III |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
T' wave amplitude in lead III |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
10135-2 |
|
EKG |
|
|
Observation |
|
|
|
0 |
T' wave Amp L-III |
|
|
|
Y |
|
3; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; T prime; T' wave Amp L-III; T wave Amp L-III; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
| 101350-7 |
Consultation note |
Find |
{Setting} |
Pt |
Doc |
Orthopaedic+Trauma Surgery |
|
ACTIVE |
Orthopaedic and Trauma Surgery Consult note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
101350-7 |
|
Orthopaedic+Trauma Surgery |
|
|
Both |
|
|
|
0 |
Consult note |
|
|
|
N |
|
Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Surg; Visit note |
2.74 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101351-5 |
Has lack of transportation kept you from medical appointments, meetings, work, or from getting things needed for daily living |
Find |
^Patient |
RptPeriod |
Nom |
CMS Assessment |
|
ACTIVE |
Has lack of transportation kept you from medical appointments, meetings, work, or from getting things needed for daily living during assessment period [CMS Assessment] |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.CMS |
|
101351-5 |
|
CMS Assessment |
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Centers for Medicare and Medicaid Assessment; Finding; Findings; Job; Nominal; Occupation; Report period; Survey |
2.77 |
2.74 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: TIME_ASPCT: Decision by CMS to update the Timing to RptPeriod from Pt for all CMS Assessments; |
0 |
| 101352-3 |
Borrelia burgdorferi Ab.IgG & IgM with reflex to immunoassay panel |
- |
Ser/Plas |
Pt |
- |
|
|
ACTIVE |
Borrelia burgdorferi Ab.IgG and IgM with reflex to immunoassay panel - Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
101352-3 |
|
|
|
|
Order |
|
|
|
0 |
B burgdor IgG+IgM W reflex to IA pnl SerPl |
|
|
|
N |
|
B burg; B burgdor; B burgdor IgG+IgM W reflex to IA pnl; B burgdorferi; Bb; Burgdorf; ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; MTTT; Pan; PANEL.MICROBIOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.75 |
2.74 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 101353-1 |
Borrelia burgdorferi Ab |
Imp |
Ser |
Pt |
Ord |
IA.MTTT |
|
ACTIVE |
Borrelia burgdorferi Ab [Interpretation] in Serum Qualitative by IA.MTTT |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101353-1 |
|
IA.MTTT |
|
|
Both |
|
|
|
0 |
B burgdor Ab Ser IA.MTTT-Imp |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Lyme; Lyme disease; Lymes; MEIA; Microbiology; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101354-9 |
Borrelia afzelii+burgdorferi+garinii Ab.IgG+IgM |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
Borrelia afzelii+burgdorferi+garinii IgG+IgM Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101354-9 |
|
IA |
|
|
Both |
|
|
|
0 |
B afz+burg+gari IgG+IgM Ser Ql IA |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B afz+burg+gari; B afzelii; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101355-6 |
Borrelia afzelii+burgdorferi+garinii Ab.IgM |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
Borrelia afzelii+burgdorferi+garinii IgM Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101355-6 |
|
IA |
|
|
Both |
|
|
|
0 |
B afz+burg+gari IgM Ser Ql IA |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B afz+burg+gari; B afzelii; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin M; Immunoglobulin M; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101356-4 |
Borrelia afzelii+burgdorferi+garinii Ab |
Imp |
Ser |
Pt |
Nom |
IA.MTTT |
|
ACTIVE |
Borrelia afzelii+burgdorferi+garinii Ab [Interpretation] in Serum by IA.MTTT |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101356-4 |
|
IA.MTTT |
|
|
Both |
|
|
|
0 |
B afz+burg+gari Ab Ser IA.MTTT-Imp |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B afz+burg+gari; B afzelii; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; MEIA; Microbiology; Nominal; Point in time; Random; Serum; SR; SUDS |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101357-2 |
Borrelia burgdorferi.VlsE+OspC Ab.IgG+IgM |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
Borrelia burgdorferi.VlsE+OspC IgG+IgM Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101357-2 |
|
IA |
|
|
Both |
|
|
|
0 |
B.burgdor.VlsE+OspC IgG+IgM Ser Ql IA |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; B.burgdor.VlsE+OspC Ab.IgG+IgM; Bb; Burgdorf; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Lyme; Lyme disease; Lymes; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101358-0 |
Borrelia burgdorferi Ab |
Imp |
Ser |
Pt |
Nom |
IA.MTTT |
|
ACTIVE |
Borrelia burgdorferi Ab [Interpretation] in Serum by IA.MTTT |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101358-0 |
|
IA.MTTT |
|
|
Both |
|
|
|
0 |
B burgdor Ab Ser IA.MTTT-Imp |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Lyme; Lyme disease; Lymes; MEIA; Microbiology; Nominal; Point in time; Random; Serum; SR; SUDS |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101359-8 |
Bioterrorism agent panel |
- |
XXX |
Pt |
- |
Non-probe.amp.tar |
|
ACTIVE |
Bioterrorism agent panel - Specimen by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
101359-8 |
|
Non-probe.amp.tar |
|
|
Order |
|
|
|
0 |
Bioterrorism agnt pnl Spec NAA+non-probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bioterrorism agnt pnl; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.75 |
2.74 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 10136-0 |
T' wave amplitude.lead V1 |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
T' wave amplitude in lead V1 |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
10136-0 |
|
EKG |
|
|
Observation |
|
|
|
0 |
T' wave Amp L-V1 |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; T prime; T' wave Amp L-V1; T wave Amp L-V1; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
| 101360-6 |
Bacillus anthracis plasmid pXO1 DNA |
PrThr |
Bld |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Bacillus anthracis plasmid pXO1 DNA [Presence] in Blood by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101360-6 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
B anthracis plsmd pXO1 DNA Bld Ql NAA+ |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Anthrax; B anthracis; B anthracis plasmid pXO1; B anthracis plasmid pXO1 DNA; Blood; Charbon; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Malignant carbuncle; Malignant pustule; Microbiology; Milzbrand; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Splenic fever; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood; Woolsorters disease |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101361-4 |
Bacillus anthracis plasmid pXO2 DNA |
PrThr |
Bld |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Bacillus anthracis plasmid pXO2 DNA [Presence] in Blood by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101361-4 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
B anthracis plsmd pXO2 DNA Bld Ql NAA+ |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Anthrax; B anthracis; B anthracis plasmid pXO2; B anthracis plasmid pXO2 DNA; Blood; Charbon; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Malignant carbuncle; Malignant pustule; Microbiology; Milzbrand; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Splenic fever; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood; Woolsorters disease |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101362-2 |
Bacillus anthracis DNA |
PrThr |
Bld |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Bacillus anthracis DNA [Presence] in Blood by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101362-2 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
B anthracis DNA Bld Ql NAA+non-probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Anthrax; B anthracis; Blood; Charbon; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Malignant carbuncle; Malignant pustule; Microbiology; Milzbrand; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Splenic fever; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood; Woolsorters disease |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101363-0 |
Yersinia pestis DNA |
PrThr |
Bld |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Yersinia pestis DNA [Presence] in Blood by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101363-0 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
Y pestis DNA Bld Ql NAA+non-probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; P pestis; Pasturella pestis; PCR; Plague; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood; Y pestis |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101364-8 |
Francisella tularensis DNA |
PrThr |
Bld |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Francisella tularensis DNA [Presence] in Blood by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101364-8 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
F tular DNA Bld Ql NAA+non-probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; F tular; F tularensis; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Tularemia; WB; Whole blood |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101365-5 |
Coxiella burnetii DNA |
PrThr |
Bld |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Coxiella burnetii DNA [Presence] in Blood by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101365-5 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
C burnet DNA Bld Ql NAA+non-probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; C burnet; C burnetii; Coxiella burnettii; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Q fev; Q fever; QBR; Qfever; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101366-3 |
Ebola virus RNA |
PrThr |
Bld |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Ebola virus RNA [Presence] in Blood by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101366-3 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
EBOV RNA Bld Ql NAA+non-probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; DNA NUCLEIC ACID PROBE; DNA probe; EBO; EBOV; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101367-1 |
Marburg virus RNA |
PrThr |
Bld |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Marburg virus RNA [Presence] in Blood by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101367-1 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
MARV RNA Bld Ql NAA+non-probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; MARV; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101368-9 |
Bacillus anthracis DNA |
PrThr |
Bld.pos growth |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Bacillus anthracis DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101368-9 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
B anthracis DNA Bld Pos Ql NAA+non-probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Anthrax; B anthracis; Bld Pos; Blood; Charbon; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Malignant carbuncle; Malignant pustule; Microbiology; Milzbrand; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Splenic fever; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood; Woolsorters disease |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101369-7 |
Bacillus anthracis plasmid pXO1 DNA |
PrThr |
Bld.pos growth |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Bacillus anthracis plasmid pXO1 DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101369-7 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
B anthracis plsmd pXO1 DNA Bld Pos Ql |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Anthrax; B anthracis; B anthracis plasmid pXO1; B anthracis plasmid pXO1 DNA; Bld Pos; Blood; Charbon; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Malignant carbuncle; Malignant pustule; Microbiology; Milzbrand; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Splenic fever; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood; Woolsorters disease |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 10137-8 |
T' wave amplitude.lead V2 |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
T' wave amplitude in lead V2 |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
10137-8 |
|
EKG |
|
|
Observation |
|
|
|
0 |
T' wave Amp L-V2 |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; T prime; T' wave Amp L-V2; T wave Amp L-V2; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
